Meiji Yasuda Asset Management Co Ltd. Sells 12,562 Shares of Xylem Inc. $XYL

Key Points

• Meiji Yasuda Asset Management reduced its Xylem stake by 30.2%, selling 12,562 shares and retaining 29,055 shares valued at about $4.29 million.
• Xylem's board authorized a $1.50 billion share buyback (up to 4.8% of outstanding shares) and raised the quarterly dividend to $0.43 from $0.40 (annualized $1.72, ~1.4% yield).
• Recent results: Xylem reported $1.42 EPS with revenue up 6.3% year-over-year and set FY2026 guidance of $5.35–$5.56 in EPS.

Meiji Yasuda Asset Management Co Ltd. decreased its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 30.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,055 shares of the industrial products company's stock after selling 12,562 shares during the period. Meiji Yasuda Asset Management Co Ltd.'s holdings in Xylem were worth $4,286,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. SJS Investment Consulting Inc. grew its stake in shares of Xylem by 1,844.4% in the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company's stock worth $26,000 after buying an additional 166 shares during the last quarter. First Horizon Corp purchased a new position in Xylem during the third quarter valued at $30,000. Ramirez Asset Management Inc. boosted its holdings in Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company's stock worth $30,000 after acquiring an additional 100 shares in the last quarter. Grey Fox Wealth Advisors LLC bought a new stake in Xylem in the third quarter worth $34,000. Finally, Caldwell Trust Co purchased a new stake in shares of Xylem in the second quarter worth $41,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Trading Down 2.4%

Shares of NYSE:XYL opened at $123.16 on Monday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a market cap of $29.95 billion, a P/E ratio of 31.42, a PEG ratio of 1.76 and a beta of 1.17. The stock's fifty day moving average price is $135.51 and its 200-day moving average price is $140.59.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, hitting analysts' consensus estimates of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.The company's revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business posted $1.18 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Sell-side analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem announced that its Board of Directors has initiated a stock buyback program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the industrial products company to buy up to 4.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's management believes its stock is undervalued.

Xylem Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Tuesday, February 24th will be issued a dividend of $0.43 per share. The ex-dividend date of this dividend is Tuesday, February 24th. This is a positive change from Xylem's previous quarterly dividend of $0.40. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. Xylem's dividend payout ratio is presently 43.88%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on XYL. Robert W. Baird set a $161.00 price target on Xylem in a research report on Wednesday, February 11th. TD Cowen reissued a "hold" rating on shares of Xylem in a research report on Monday, February 23rd. Stifel Nicolaus decreased their target price on shares of Xylem from $178.00 to $175.00 and set a "buy" rating for the company in a report on Wednesday, February 11th. Weiss Ratings reiterated a "buy (b-)" rating on shares of Xylem in a research note on Monday, December 29th. Finally, Barclays cut their price target on shares of Xylem from $166.00 to $156.00 and set an "overweight" rating on the stock in a report on Wednesday, February 11th. Nine analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $158.08.

Xylem Profile

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.